<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03116191</url>
  </required_header>
  <id_info>
    <org_study_id>VA1001</org_study_id>
    <nct_id>NCT03116191</nct_id>
  </id_info>
  <brief_title>Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects</brief_title>
  <official_title>Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanwa Kagaku Kenkyusho Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanwa Kagaku Kenkyusho Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to demonstrate efficacy of SK-1404 against placebo for the
      treatment of subjects with nocturia due to nocturnal polyuria, during 4 weeks of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 23, 2017</start_date>
  <completion_date type="Actual">December 15, 2017</completion_date>
  <primary_completion_date type="Actual">December 15, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in mean number of nocturnal voids</measure>
    <time_frame>4 weeks</time_frame>
    <description>Assessed by the voiding diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from base line in mean nocturnal urine volume</measure>
    <time_frame>4 weeks</time_frame>
    <description>Assessed by the voiding diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from base line in mean time to first awakening to void</measure>
    <time_frame>4 weeks</time_frame>
    <description>Assessed by the voiding diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from base line in mean Nocturnal Polyuria Index (NPI)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Assessed by the voiding diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from base line in the score of Nocturia-Specific Quality-of-Life Questionnaire (N-QoL)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Assessed by the voiding diary</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Nocturia Due to Nocturnal Polyuria</condition>
  <arm_group>
    <arm_group_label>SK-1404 high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SK-1404 middle dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SK-1404 low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SK-1404</intervention_name>
    <description>4 weeks of repeated administration of SK-1404 to the patients of nocturia</description>
    <arm_group_label>SK-1404 high dose</arm_group_label>
    <arm_group_label>SK-1404 middle dose</arm_group_label>
    <arm_group_label>SK-1404 low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>4 weeks of repeated administration of Placebo to the patients of nocturia</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  5 &gt; nocturnal voids â‰¥2

          -  NPI &gt;0.33

        Exclusion Criteria:

          -  Polydipsia

          -  Cardiac failure

          -  Syndrome of inappropriate antidiuretic hormone secretion

          -  Hyponatraemia

          -  Uncontrolled diabetes mellitus

          -  Uncontrolled hypertension

          -  Moderate or severe over-active bladder (OAB)

          -  Severe benign prostate hyperplasia (BPH)

          -  Sleep apnoea

          -  Interstitial cystitis

          -  Stress urinary incontinence

          -  Diabetes insipidus

          -  Complication or a history of urological cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Investigational site (there may be other sites in this country)</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nocturia</mesh_term>
    <mesh_term>Polyuria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

